New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
AptarGroup, Inc.
ATR
Shape
US Flag

NYSE

11B

Medical - Instruments & Supplies

Next Earning date - 24 Oct 2024

11B

Medical - Instruments & Supplies

Next Earning date - 24 Oct 2024

166.33USD
Shape-2.30 ( -1.36%)
favorite-chart

Relative Strenght

70
favorite-chart

Volume Buzz

-22%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

2%

Quote Panel

Shape
Updated October 22, 2024
1W 0.17 % 1M 6.65 % 3M 14.25 % 1Y 38.62 %

Key Metrics

Shape
  • Market Cap

    11.04B


  • Shares Outstanding

    66.39M


  • Share in Float

    65.88M


  • Dividende

    1.8


  • Earning Date

    24 Oct 2024


  • Price Target

    166.33


  • Average Volume

    279729


  • Beta

    0.574


  • Range

    120.36-169.66


  • Industry

    Medical - Instruments & Supplies


  • Website

    https://www.aptar.com


  • Sector

    Healthcare


Fundamentals

Shape

31.80x

P/E Ratio

3.15x

P/S Ratio

4.67x

P/B Ratio

0.5

Debt/Equity

9.0%

Net Margin

$4.8

EPS

How ATR compares to sector?

P/E Ratio

Relative Strength

Shape

ATR

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$4B

Shape321%

2025-Revenue

$5.68

Shape318%

2025-EPS

$752M

Shape282%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

DBS Bank

upgrade

Previous: Not converted

2024-10-16

Now: Buy

Jefferies

upgrade

Previous: Not converted

2024-10-14

Now: Buy

William Blair

upgrade

Previous: Not converted

2024-04-29

Now: Outperform

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+1%

0.95
vs 0.94

Q4.22

arrow
arrow

-1%

0.92
vs 0.93

Q1.23

arrow
arrow

-1%

0.95
vs 0.96

Q2.23

arrow
arrow

+28%

1.23
vs 0.96

Q3.23

arrow
arrow

+46%

1.39
vs 0.95

Q4.23

arrow
arrow

+32%

1.21
vs 0.92

Q1.24

arrow
arrow

+33%

1.26
vs 0.95

Q2.24

arrow
arrow

+11%

1.37
vs 1.23

Q3.24

arrow
arrow

+2%

1.42
vs 1.39

Q4.24

arrow
arrow

+8%

1.31
vs 1.21

Sales GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

+1%

836.9M  vs 825.4M

Q4.22

arrow
arrow

-2%

795.9M  vs 814M

Q1.23

arrow
arrow

+2%

860.1M  vs 844.9M

Q2.23

arrow
arrow

+6%

895.9M  vs 844.5M

Q3.23

arrow
arrow

+7%

893M  vs 836.9M

Q4.23

arrow
arrow

+5%

838.5M  vs 795.9M

Q1.24

arrow
arrow

+6%

915.4M  vs 860.1M

Q2.24

arrow
arrow

+2%

910.1M  vs 895.9M

Q3.24

arrow
arrow

+3%

922.3M  vs 893M

Q4.24

arrow
arrow

+5%

883.5M  vs 838.5M

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

+3%

0.03
vs 0.03

Q4.22

arrow
arrow

+3%

0.03
vs 0.03

Q1.23

arrow
arrow

+3%

0.03
vs 0.03

Q2.23

arrow
arrow

+4%

0.04
vs 0.03

Q3.23

arrow
arrow

+4%

0.04
vs 0.04

Q4.23

arrow
arrow

+3%

0.03
vs 0.04

Q1.24

arrow
arrow

+4%

0.04
vs 0.03

Q2.24

arrow
arrow

+4%

0.04
vs 0.04

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

377

377
vs 397

-5%

Q4.22

arrow
arrow

382

382
vs 377

1%

Q1.23

arrow
arrow

408

408
vs 382

7%

Q2.23

arrow
arrow

422

422
vs 408

3%

Q3.23

arrow
arrow

421

421
vs 422

0%

Q4.23

arrow
arrow

464

464
vs 421

10%

Q1.24

arrow
arrow

466

466
vs 464

0%

Q2.24

arrow
arrow

458

458
vs 466

-2%

Earnings Growth

Latest News